bioAffinity Technologies, Inc. (NASDAQ:BIAFW) Short Interest Down 37.5% in May

bioAffinity Technologies, Inc. (NASDAQ:BIAFW) was the recipient of a large decrease in short interest during the month of May. As of May 31st, there was short interest totalling 500 shares, a decrease of 37.5% from the May 15th total of 800 shares. Based on an average trading volume of 2,800 shares, the short-interest ratio is currently 0.2 days.

bioAffinity Technologies Price Performance

NASDAQ BIAFW remained flat at $0.59 during trading hours on Friday. bioAffinity Technologies has a 12-month low of $0.05 and a 12-month high of $0.90. The stock has a 50 day simple moving average of $0.41 and a two-hundred day simple moving average of $0.29.

bioAffinity Technologies Company Profile

bioAffinity Technologies, Inc, a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat lung cancer and other diseases of the lung at the cellular level.